Donner Corp. International Reiterates Buy Recommendation On Medix Resources, Inc.
SANTA ANA, Calif., April 25 /PRNewswire/ -- The following is being issued by Donner Corporation International, a member of the National Association of Securities Dealers, CRD number 37702:
Donner Corp. International, an Investment Banking firm headquartered in Santa Ana, Calif., today reiterated its Buy Recommendation on Medix Resources, Inc. (AMEX:MXR), Englewood, Colorado. Through its wholly-owned subsidiary, Cymedix Lynx Corporation, Medix Resources offers a suite of fully secured patented Internet communications software products to the healthcare industry.
The reiteration is based on several recent announcements by Medix, including:
-- Listing of its common stock on the American Stock Exchange.
Previously, Medix traded under the symbol MDIX on the Over the Counter
Bulletin Board. This provides brokers greater freedom to recommend
Medix and could significantly increase the number of investors in the
Company. Also, it should reduce the cost of raising capital and
provide Medix greater flexibility in future financings.
-- Appointment of John T. Lane as Chairman of the Board of Directors.
Lane is retired managing director of J.P. Morgan, a major financial
institution, and services as vice chairman of a large regional HMO and
director of a major regional healthcare provider. Medix believes this
combination of financial and health care experience will prove
invaluable in its growth strategy.
"We believe Medix' stock is undervalued and poised to grow significantly as its patented line of B2B Internet healthcare ("iHealth") management solutions continues to gain industry-wide recognition," Donner said.
Copies of the Donner report on Medix Resources, Inc. are available at 1-800-324-6050.
Any information or opinion provided in this report does not solicit or make an offer to buy or sell any securities or any options, futures or other derivatives related to such securities herein. DCI and its affiliates may trade for their own accounts in any securities of the issuer or in related securities. DCI or its affiliates, directors, officers and employees, may have a long or short position in securities of the issuer or related investments. DCI or its affiliates may from time to time perform investment banking or other services for, or solicit investment banking or other business from, any entity mentioned in this report for a fee. This research report has been prepared for general circulation and is circulated for general information only. It does not have regard to the specific investment objective, financial situation and the particular need of any specific person who may receive this report. Investors should seek financial advice regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realized. Investors should note that income from such securities, if any, may fluctuate and the value or stock price may rise or fall substantially. Accordingly, investors may receive less than originally invested. Past performance is not indicative of future performance. Copyright 2000 DCI. SOURCE Donner Corporation International
-0- 04/25/2000
/CONTACT: Donner Corp., 1-800-324-6050/ |
